Joanna and Su Tao communicated a few words and were in a good mood.

On the one hand, Su Tao took the initiative to contact him, which shows that this oriental man has not forgotten him. On the other hand, the suggestions given by Su Tao are indeed worth adopting.

Tusca Group has also established a subsidiary in London. Because the European Medicines Quality Administration is located in London, all pharmaceutical companies and pharmaceutical talents are gathered there. The subsidiary can not only easily recruit various top talents, know the latest important news in the industry, but also enjoy policy support. It happily receives a considerable scientific research funding subsidy every year, which is a huge investment.

The British government has called for Brexit for many years, so it is a foregone conclusion that the European Medicines Agency relocates to Amsterdam, the Netherlands. The building is already being designed and is expected to be moved in in April next year. At the same time, top pharmaceutical giants like Tusca and Neuy have long registered companies in the Netherlands, and have purchased land and built office addresses for new companies near the administration.

The international pharmaceutical industry will inevitably usher in turmoil due to Brexit, London will gradually lose its title as the world's pharmaceutical capital, and Amsterdam will become the new center of the pharmaceutical industry.

When many people give up London, those who are interested can smell the business opportunities here. If so many companies move out of London, it also means that this is the best time to buy at the bottom.

High-rise buildings can be built in a short time, but the industry atmosphere and the difficulty of talent gathering require time to settle.

However, in their eyes, different people have different interests.

Su Tao and Joanna's focus are obviously different from Albert.

The business opportunity Albert targets is that when a large number of pharmaceutical companies leave London, there will definitely be opportunities to buy at the bottom at a low price. For example, the headquarters building will be sold at a low price. If you buy it in the near future, you will definitely have room for value-added in the future.

During the communication process, Su Tao and Joanna focused on another entry point. Su Tao's interest in R&D talents in the pharmaceutical industry is obviously higher than that in tall buildings.

There are more than 200,000 practitioners engaged in the pharmaceutical research industry in London. With the European Drug Quality Administration moving to Amsterdam, at least 70% of these people will face the trouble of unemployment or reduced income. After all, most of these people are natives in London, or have lived in London for a long time. Let them leave the familiar environment they have been used to and develop in another city. They will definitely consider whether to immigrate or live in another city.

The Tusca Group has been doing poaching secretly for so many years, but the core talents have not been recruited, so it is undoubtedly the best time to meet.

The Tusca Group only needs to stick to its position and continue to lock London as its R&D center. It can poach the core talents of its competitors and will definitely gain the lead in talent competition.

As for Su Tao's plan to set up an international R&D center in London to engage in research on Chinese patent medicines and Western medicines.

With the successful acquisition of Ruixing Group by Sanwei Group, Sanwei Group has not only operated traditional Chinese medicine, but also had some involvement in Western medicine. With the investment in technology from Tusca, Ruixing's R&D center's scientific research level has been greatly improved, but it has a huge gap with the international top Western medicine research level.

If you want to shorten the gap, it is not possible to solve it by transferring technology by others or hiring talents with high salaries. While practicing internal skills, you must also go out and establishing a R&D center abroad is the appropriate method.

Taking the Internet as an example, why does Lian want to set up its R&D center in Silicon Valley, USA? Because Lenovo knows that the top computer technology R&D talents are gathered there. As long as Lenovo sets up its R&D center, it can not only know the latest technical directions and trends at any time, but also recruit suitable candidates for it as quickly as possible.

As for Huawei, it has overseas R&D centers in 16 cities around the world, Paris, France is Huawei's R&D center in the field of technical standards research, Berlin, Germany is Huawei's R&D center in the field of technical standards research, Lund, Sweden is Huawei's R&D center in the field of terminal fields, and Milan, Italy is Huawei's R&D center in the field of photoelectric and microwave transmission.

Therefore, if you want to further improve China's medical level, you have to set up R&D centers around the world. London is the most suitable city, especially with the impact of Brexit, the talent market in the field of life science research and development in London will inevitably fluctuate significantly. It is the most appropriate time to enter at this time.

The conversation between Su Tao and Joanna on the phone was mainly about the large number of research talents in London. These talents are the most worthy of buying at the bottom and are also the most scarce resource for Sanwei Group today.

Although Sanwei Pharmaceutical has performed well in the research and development of traditional Chinese patent medicines, Su Tao feels that if you want to comprehensively improve the competitiveness of your products, you must continue to integrate with top talents. Although some people recruited have never been exposed to traditional Chinese medicine or traditional Chinese patent medicines, you can borrow their ideas and logic for developing products, so that Chinese patent medicines can be more in line with the development trend of modern life sciences.

As for the research on Western medicine, Su Tao also feels that it is beneficial to expand the influence of Chinese patent medicines, whether it is Western medicine or Chinese medicine, there are areas for mutual reference. To enhance the competitiveness of Sanwei Group in the field of Western medicine, it is also beneficial to expand the influence of Chinese patent medicines.

It is very simple logic. If a company can produce high-quality Western medicines, the effectiveness of the Chinese patent medicines it develops will definitely not be bad.

Su Tao decided to jointly register a R&D company with Joanna. Tusca Group and Sanwei Group each invested 2.5 billion pounds, accounting for 50% of the shares respectively, and both parties can enjoy the R&D results.

£2.5 billion is not a small amount of money. Both the Tusca Group and Sanwei Group are investing heavily. However, from Joanna's attitude, there should be no big problem. After all, Su Tao is nominally a shareholder of the Tusca Group, and the two parties have cooperated more and more times. At present, the investment of the Tusca Group in China has also been reported quickly, occupying half of China's high-end medical devices and pharmaceutical products.

Through this cooperation, Joanna has firmly taken up her position on the board of directors of the Tusca Group. Her decisions can generally be trusted by board members. After all, she saved the group from the crisis of the Qishanling Village virus and protected the interests of all directors.

"Nei Pharmaceuticals, Elber Pharmaceuticals, and Ferry Pharmaceuticals are now very strange about the development ideas of Tusca Pharmaceuticals, because we not only focus on China as the business market, but also invest a lot of money in the research of Chinese patent medicines." Joanna shook her head and sighed, "I am under a lot of pressure on the board of directors. Although all the directors trust my decision, I know that many people are watching my jokes."

"Are you acting cute with me, asking for hugs, and asking for comfort?" Su Tao asked with a smile.

"Who is acting cute with you? I just tell you that I have put a lot of effort into you, and you must not let me down." Joanna's face turned red and her tone became very serious.

"Hasn't the Tusca Group tasted the sweetness?" Su Tao shook his head and said lightly, "The stock price of your group has been soaring. There is no profitable deal in the world. If you want to continue making money, you have to invest continuously. You have a good vision and know how to invest in me. You are an excellent businessman."

Joanna laughed, "Is there anyone who gilds her face like this?"

Su Tao chuckled a little, and suddenly his tone became serious, "Since I decided to invest in Chinese patent medicine, I have to make a gamble and not be stubborn. There are two things, I need your help, which has a decisive effect on whether Chinese patent medicine can rise, which is related to life and death."

Joanna also showed a solemn expression, and she said in a deep voice: "Oh, let's hear it."

"First, I am pushing the UK to lift the ban on plant medicines, and now it has made good progress. Second, the plan is also underway for amending the EU's plant medicine regulations and lowering the entry threshold for Chinese patent medicines." Su Tao's voice became increasingly low, "As one of the four major pharmaceutical giants, the Tusca Group must have participated in the ban on plant medicines at the beginning?"

"You mean, want me to stand opposite to those pharmaceutical groups that silently promote the ban?" Joanna smiled bitterly. This was really a very difficult requirement.

On the surface, Neui Pharmaceutical, Elber Pharmaceutical, Ferry Pharmaceutical, Tusca Pharmaceutical, and the four major pharmaceutical giants are in a competitive relationship, but they have a secret cooperative relationship. When it affects the core interests of the industry, they will unite and unite to the outside world.

When the ban on plant medicine was promoted, the four giants were just aware of the threat of Chinese patent medicine. If Chinese patent medicines replace Western medicines and become mainstream medicines, it means that the entire Western medicine industry will suffer huge losses. So they united and let the British government and the European Medicines Quality Administration pass relevant regulations.

"If you don't break, you won't stand." Su Tao continued to brainwash Joanna. "From the development momentum in recent years, the growth rate of Chinese patent medicines far exceeds the development speed of new Western medicine products. If you want to maintain high growth, it is better to start with Chinese patent medicines. You should know very well about Sanwei Pharmaceuticals. Not only does it have rigorous R&D technology, but the product quality is far beyond the products on the market. As long as Tusca continues to pay attention to and support the development of Chinese patent medicines, there is a chance to become the leader of the pharmaceutical industry. What about Ferrey Pharmaceuticals and Neui Pharmaceuticals are defeated by their subordinates and directly trampling them under their feet. And you, becoming the queen of the pharmaceutical industry, everyone has to look up to..."

Joanna remained silent for a long time and didn't say anything.

Seeing that there was no movement, Su Tao said curiously: "Why don't you stop talking? Are you completely immersed in your fantasy for a better future? Come back quickly."

Joanna took a light breath and smiled helplessly: "I'm thinking about the consequences. If I'm targeted by the three families, there will be no good ending."
Chapter completed!